Mankin score | | | | |
|---|
Group I | Group II | Group III | Group IV | Group V |
|---|
1 (1-1) | 10 (9-12) | 1 (0-2) | 3 (2-4) | 10 (8-11) |
| | P1 = 0.0088 | P2 = 1 | P3 = 0.0742 | P4 = 0.0102 |
| | | P5 = 0.0017 | P6 = 0.0038 | P7 = 0.6213 |
| | | | P8 = 0.0705 | P9 = 0.0022 |
| | | | | P10 = 0.0052 |
Safranin O
| | | | |
Group I
|
Group II
|
Group III
|
Group IV
|
Group V
|
1 (1-1) | 18.7 (16-20) | 0.7 (0-1) | 1.3 (1-2) | 15 (12-17) |
| | P1 = 0.0056 | P2 = 0.4226 | P3 = 0.4226 | P4 = 0.0117 |
| | | P5 = 0.0036 | P6 = 0.0039 | P7 = 0.1461 |
| | | | P8 = 0.2302 | P9 = 0.0087 |
| | | | | P10 = 0.0096 |
- Group I: the control; Group II: ACLT + MM; Group III: ACLT + MM + ESWT 1×/week; Group IV: ACLT + MM + ESWT 2×/week; Group V: ACLT + MM + ESWT 3×/week.
- ACLT: anterior cruciate ligament transection; MM: medial meniscectomy; ESWT: extracorporeal corporeal shockwave therapy.
- P1: Group I vs Group II P2: Group I vs Group III P3: Group I vs Group IV.
- P4: Group I vs Group V P5: Group II vs Group III P6: Group II vs Group IV.
- P7: Group II vs Group V P8: Group III vs Group IV P9: Group III vs Group V.
- P10: Group IV vs Group V.
- The P values were obtained using ANOVA and post hoc test with Bonferoni correction among five groups, and the Mann-Whitney U test between two groups.
